DC Field | Value | Language |
---|---|---|
dc.contributor.author | N Y Yoon | - |
dc.contributor.author | B S Min | - |
dc.contributor.author | Hyeong Kyu Lee | - |
dc.contributor.author | J C Park | - |
dc.contributor.author | J S Choi | - |
dc.date.accessioned | 2017-04-19T09:03:43Z | - |
dc.date.available | 2017-04-19T09:03:43Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/7209 | - |
dc.description.abstract | In order to isolate substances that inhibit the hemolytic activity of human serum against erythrocytes, we have evaluated whole plants of the Orostachys japonicus species with regard to its anti-complement activity, and have identified its active principles following activity-guided isolation. A methanol extract of the O. japonicus, as well as its n-hexane soluble fraction, exhibited significant anti-complement activity on the complement system, which was expressed as total hemolytic activity. A bioassay-guided chromatographic separation of the constituents resulted in the isolation of three known compounds 1-3 from the active n-hexane fraction. The structure of these compounds were analyzed, and they were identified as hydroxyhopanone (1), β-sitosteryl-3-O-β-D-glucopyranosyl-6′-O-palmitate (2), and β-sitosteryl-3-O-β-D-glucopyranoside (3), respectively. of these compounds, compound 2 exhibited potent anti-complement activity (IC50 = 1.0 ± 0.1 μM) on the classical pathway of the complement, as compared to tiliroside (IC50 = 76.5 ± 1.1 μM), which was used as a positive control. However, compounds 1 and 3 exhibited no activity in this system. | - |
dc.publisher | Pharmaceutical Soc Korea | - |
dc.title | A potent anti-complementary acylated sterol glucoside from Orostachys japonicus | - |
dc.title.alternative | A potent anti-complementary acylated sterol glucoside from Orostachys japonicus | - |
dc.type | Article | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.number | 8 | - |
dc.citation.endPage | 896 | - |
dc.citation.startPage | 892 | - |
dc.citation.volume | 28 | - |
dc.contributor.affiliatedAuthor | Hyeong Kyu Lee | - |
dc.contributor.alternativeName | 윤나영 | - |
dc.contributor.alternativeName | 민병선 | - |
dc.contributor.alternativeName | 이형규 | - |
dc.contributor.alternativeName | 박종철 | - |
dc.contributor.alternativeName | 최재수 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, vol. 28, no. 8, pp. 892-896 | - |
dc.identifier.doi | 10.1007/bf02973873 | - |
dc.subject.keyword | β-sitosteryl-3-o-β-d-glucopyranosyl-6′-o-palmitate | - |
dc.subject.keyword | anti-complement activity | - |
dc.subject.keyword | crassulaceae | - |
dc.subject.keyword | orostachys japonicus a. berger | - |
dc.subject.local | β-sitosteryl-3-o-β-d-glucopyranosyl-6′-o-palmitate | - |
dc.subject.local | anti-complement activity | - |
dc.subject.local | Anti-complement activity | - |
dc.subject.local | anticomplement activity | - |
dc.subject.local | Anticomplement activity | - |
dc.subject.local | crassulaceae | - |
dc.subject.local | orostachys japonicus a. berger | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.